Literature DB >> 2285261

Cerebrospinal fluid immune complexes in patients exposed to Borrelia burgdorferi: detection of Borrelia-specific and -nonspecific complexes.

P K Coyle1, S E Schutzer, A L Belman, L B Krupp, M G Golightly.   

Abstract

We analyzed cerebrospinal fluid (CSF) from 32 patients with neurological symptoms and evidence of Borrelia burgdorferi infection (29 were seropositive as determined by enzyme-linked immunosorbent assay, 2 were cell-mediated immune positive, and 1 had been seropositive as shown by enzyme-linked immunosorbent assay 9 months previously). CSF immune complexes were found in 22 (69%) of 32 patients; in 18, there was sufficient sample to isolate immune complexes. By enzyme-linked immunosorbent assay, isolated immune complexes from 10 of these 18 patients contained antibody specific for B. burgdorferi antigens. The isotypes were IgG (n = 8), IgM (n = 3), and IgA (n = 2). By immunoblot, these antibodies were directed against B. burgdorferi 41-kDa antigen and occasionally against the 33- and 17-kDa antigens. Anti-B. burgdorferi IgM was present in patients with acute neurological symptoms, was predominantly complexed rather than free, and decreased with clinical recovery in the one serial study. Three patients were nonreactive for free CSF antibodies, but had complexed antibodies to the organism. The preliminary finding of specific B. burgdorferi components in immune complexes in CSF suggests an active process triggered by the organism, even in the absence of other CSF abnormalities.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2285261     DOI: 10.1002/ana.410280603

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  8 in total

1.  Simultaneous expression of Borrelia OspA and OspC and IgM response in cerebrospinal fluid in early neurologic Lyme disease.

Authors:  S E Schutzer; P K Coyle; L B Krupp; Z Deng; A L Belman; R Dattwyler; B J Luft
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

2.  Quality sample collection, handling, and preservation for an effective microbial forensics program.

Authors:  Bruce Budowle; Steven E Schutzer; James P Burans; Douglas J Beecher; Thomas A Cebula; Ranajit Chakraborty; William T Cobb; Jacqueline Fletcher; Martha L Hale; Robert B Harris; Michael A Heitkamp; Frederick Paul Keller; Cheryl Kuske; Joseph E Leclerc; Babetta L Marrone; Thomas S McKenna; Stephen A Morse; Luis L Rodriguez; Nancy B Valentine; Jagjit Yadev
Journal:  Appl Environ Microbiol       Date:  2006-10       Impact factor: 4.792

3.  Use of serum immune complexes in a new test that accurately confirms early Lyme disease and active infection with Borrelia burgdorferi.

Authors:  M Brunner; L H Sigal
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

Review 4.  Diagnosis of lyme borreliosis.

Authors:  Maria E Aguero-Rosenfeld; Guiqing Wang; Ira Schwartz; Gary P Wormser
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

5.  Preferential presence of decorin-binding protein B (BBA25) and BBA50 antibodies in cerebrospinal fluid of patients with neurologic Lyme disease.

Authors:  Erol Fikrig; Patricia K Coyle; Steven E Schutzer; Manchuan Chen; Zhidian Deng; Richard A Flavell
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

Review 6.  The pathogenesis of lyme neuroborreliosis: from infection to inflammation.

Authors:  Tobias A Rupprecht; Uwe Koedel; Volker Fingerle; Hans-Walter Pfister
Journal:  Mol Med       Date:  2008 Mar-Apr       Impact factor: 6.354

7.  Early and specific antibody response to OspA in Lyme Disease.

Authors:  S E Schutzer; P K Coyle; J J Dunn; B J Luft; M Brunner
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

8.  Improved culture conditions for the growth and detection of Borrelia from human serum.

Authors:  Eva Sapi; Namrata Pabbati; Akshita Datar; Ellen M Davies; Amy Rattelle; Bruce A Kuo
Journal:  Int J Med Sci       Date:  2013-02-18       Impact factor: 3.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.